SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-18-002392
Filing Date
2018-08-14
Accepted
2018-08-14 06:04:51
Documents
44
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1822019.htm 10-Q 424260
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 9828
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10046
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 7340
  Complete submission text file 0001178913-18-002392.txt   1980640

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT atms-20180630.xml EX-101.INS 326172
6 XBRL TAXONOMY EXTENSION SCHEMA atms-20180630.xsd EX-101.SCH 27741
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20180630_cal.xml EX-101.CAL 26782
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20180630_def.xml EX-101.DEF 85281
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20180630_lab.xml EX-101.LAB 164451
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20180630_pre.xml EX-101.PRE 132068
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

IRS No.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24431 | Film No.: 181014099
SIC: 2890 Miscellaneous Chemical Products